|
JP3917662B2
(ja)
|
1996-02-14 |
2007-05-23 |
日立化成工業株式会社 |
非複屈折性光学用樹脂組成物及びこれを用いた光学用素子
|
|
KR100338610B1
(ko)
|
1996-09-04 |
2002-05-27 |
디. 제이. 우드, 스피겔 알렌 제이 |
인다졸 유도체 및 포스포디에스터라제 (pde) 유형 iv 및 종양괴사인자 (tnf) 생산의 억제제로서 그의 용도
|
|
US6258822B1
(en)
*
|
1997-08-06 |
2001-07-10 |
Abbott Laboratories |
Urokinase inhibitors
|
|
US6133290A
(en)
|
1998-07-31 |
2000-10-17 |
Eli Lilly And Company |
5-HT1F agonists
|
|
US6995162B2
(en)
|
2001-01-12 |
2006-02-07 |
Amgen Inc. |
Substituted alkylamine derivatives and methods of use
|
|
US20030134836A1
(en)
|
2001-01-12 |
2003-07-17 |
Amgen Inc. |
Substituted arylamine derivatives and methods of use
|
|
US7105682B2
(en)
|
2001-01-12 |
2006-09-12 |
Amgen Inc. |
Substituted amine derivatives and methods of use
|
|
US20020147198A1
(en)
|
2001-01-12 |
2002-10-10 |
Guoqing Chen |
Substituted arylamine derivatives and methods of use
|
|
US7102009B2
(en)
|
2001-01-12 |
2006-09-05 |
Amgen Inc. |
Substituted amine derivatives and methods of use
|
|
CN1656079A
(zh)
|
2002-05-31 |
2005-08-17 |
卫材株式会社 |
吡唑化合物和含有该化合物的药物组合物
|
|
JP4594925B2
(ja)
|
2003-02-28 |
2010-12-08 |
ニッポネックス インコーポレイテッド |
増殖亢進性、血管新生性及び炎症性疾患の治療に有用な２−オキソ−１，３，５−パーヒドロトリアザピン誘導体
|
|
EP1602647B1
(en)
|
2003-03-07 |
2013-10-16 |
Santen Pharmaceutical Co., Ltd. |
Novel compound having 4-pyridylalkylthio group as substituent
|
|
EP1617840A4
(en)
|
2003-05-01 |
2008-08-20 |
Bristol Myers Squibb Co |
PYRAZOLE AMID COMPOUNDS AS KINASE INHIBITORS
|
|
US20050004133A1
(en)
|
2003-06-05 |
2005-01-06 |
Makings Lewis R. |
Modulators of VR1 receptor
|
|
US7504401B2
(en)
|
2003-08-29 |
2009-03-17 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
|
US20080293716A1
(en)
|
2004-01-30 |
2008-11-27 |
Smithkline Beecham Corporation |
Chemical Compounds
|
|
DE102004028862A1
(de)
|
2004-06-15 |
2005-12-29 |
Merck Patent Gmbh |
3-Aminoindazole
|
|
WO2006032851A1
(en)
|
2004-09-20 |
2006-03-30 |
Biolipox Ab |
Pyrazole compounds useful in the treatment of inflammation
|
|
DE102004051277A1
(de)
|
2004-10-21 |
2006-04-27 |
Merck Patent Gmbh |
Heterocyclische Carbonylverbindungen
|
|
WO2006053109A1
(en)
|
2004-11-10 |
2006-05-18 |
Synta Pharmaceuticals Corp. |
Heteroaryl compounds
|
|
JP2008519850A
(ja)
|
2004-11-10 |
2008-06-12 |
シンタ ファーマシューティカルズ コーポレーション |
Ｉｌ−１２調節化合物
|
|
US7528132B2
(en)
|
2005-01-26 |
2009-05-05 |
Schering Corporation |
Kinase inhibitors
|
|
US20060223849A1
(en)
|
2005-03-14 |
2006-10-05 |
Mjalli Adnan M |
Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors
|
|
DE102005014089A1
(de)
|
2005-03-22 |
2006-09-28 |
Schering Ag |
Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
|
|
ES2371774T3
(es)
|
2005-06-03 |
2012-01-10 |
Abbott Laboratories |
Derivados de ciclobutilamina.
|
|
FR2889526B1
(fr)
|
2005-08-04 |
2012-02-17 |
Aventis Pharma Sa |
7-aza-indazoles substitues, compositions les contenant, procede de fabrication et utilisation
|
|
US8247556B2
(en)
|
2005-10-21 |
2012-08-21 |
Amgen Inc. |
Method for preparing 6-substituted-7-aza-indoles
|
|
WO2007058626A1
(en)
|
2005-11-16 |
2007-05-24 |
S*Bio Pte Ltd |
Indazole compounds
|
|
WO2007087443A2
(en)
|
2006-01-25 |
2007-08-02 |
Synta Pharmaceuticals Corp. |
Vinyl-phenyl derivatives for inflammation and immune-related uses
|
|
CN102633783A
(zh)
|
2006-02-10 |
2012-08-15 |
转化技术制药公司 |
作为Aurora激酶抑制剂的苯并唑系衍生物、组合物和使用方法
|
|
EP1984354B1
(en)
|
2006-02-16 |
2009-08-05 |
Syngeta Participations AG |
Pesticides containing a bicyclic bisamide structure
|
|
CA2645434A1
(en)
|
2006-03-20 |
2007-09-27 |
Synta Pharmaceutical Corp. |
Benzoimidazolyl-parazine compounds for inflammation and immune-related uses
|
|
AU2007230911A1
(en)
|
2006-03-23 |
2007-10-04 |
Synta Pharmaceuticals Corp. |
Benzimidazolyl-pyridine compounds for inflammation and immune-related uses
|
|
US20080280891A1
(en)
|
2006-06-27 |
2008-11-13 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
|
PE20080888A1
(es)
|
2006-10-18 |
2008-08-26 |
Novartis Ag |
COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE LA ACIL-TRANSFERASA DE ACIL-CoA-DIACIL-GLICEROL 1 (DGAT1)
|
|
US7960567B2
(en)
|
2007-05-02 |
2011-06-14 |
Amgen Inc. |
Compounds and methods useful for treating asthma and allergic inflammation
|
|
GB0716414D0
(en)
|
2007-08-22 |
2007-10-03 |
Syngenta Participations Ag |
Novel insecticides
|
|
WO2009035951A2
(en)
|
2007-09-11 |
2009-03-19 |
Arete Therapeutics, Inc. |
Soluble epoxide hydrolase inhibitors
|
|
US8324219B2
(en)
|
2007-09-20 |
2012-12-04 |
Synta Pharmaceuticals Corp. |
Substituted benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses
|
|
US8314131B2
(en)
|
2007-09-21 |
2012-11-20 |
Amgen Inc. |
Triazole fused heteroaryl compounds and methods of use thereof
|
|
DE102007047735A1
(de)
|
2007-10-05 |
2009-04-09 |
Merck Patent Gmbh |
Thiazolderivate
|
|
US8362056B2
(en)
|
2007-11-05 |
2013-01-29 |
Array Biopharma Inc. |
4-heteroaryl-substituted phenoxyphenylacetic acid derivatives
|
|
SI2215094T1
(sl)
|
2007-11-15 |
2016-05-31 |
Ym Biosciences Australia Pty Ltd |
N vsebujoče heterociklične spojine
|
|
WO2009073788A1
(en)
|
2007-12-07 |
2009-06-11 |
Firestone Leigh H |
Compositions and methods for treating menopausal females
|
|
WO2009112445A1
(en)
|
2008-03-10 |
2009-09-17 |
Novartis Ag |
Method of increasing cellular phosphatidyl choline by dgat1 inhibition
|
|
CA2722704A1
(en)
|
2008-04-28 |
2009-11-05 |
Zalicus Pharmaceuticals Ltd. |
Cyclylamine derivatives as calcium channel blockers
|
|
AU2009262068C1
(en)
|
2008-06-27 |
2015-07-02 |
Celgene Car Llc |
Heteroaryl compounds and uses thereof
|
|
JO3041B1
(ar)
|
2008-07-25 |
2016-09-05 |
Galapagos Nv |
مركبات جديدة مفيدة لمعالجة الأمراض التنكسية والالتهابية
|
|
US20110294853A1
(en)
|
2008-09-12 |
2011-12-01 |
Benjamin Pelcman |
Bis Aromatic Compounds for Use in the Treatment of Inflammation
|
|
US8329907B2
(en)
|
2009-04-02 |
2012-12-11 |
Merck Patent Gmbh |
Autotaxin inhibitors
|
|
CA2774981A1
(en)
|
2009-09-21 |
2011-03-24 |
Vanderbilt University |
O-benzyl nicotinamide analogs as mglur5 positive allosteric modulators
|
|
US20120202814A1
(en)
|
2009-10-02 |
2012-08-09 |
Università Degli Studi Di Siena |
Compounds with ddx3 inhibitory activity and uses thereof
|
|
WO2011123937A1
(en)
|
2010-04-06 |
2011-10-13 |
University Health Network |
Kinase inhibitors and method of treating cancer with same
|
|
US8822447B2
(en)
|
2010-04-22 |
2014-09-02 |
Janssen Pharmaceutica Nv |
Indazole compounds useful as ketohexokinase inhibitors
|
|
EP2560488B1
(en)
|
2010-04-23 |
2015-10-28 |
Cytokinetics, Inc. |
Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
|
|
AR081626A1
(es)
|
2010-04-23 |
2012-10-10 |
Cytokinetics Inc |
Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
|
|
JP6112486B2
(ja)
|
2010-04-27 |
2017-04-12 |
カルシメディカ，インク． |
細胞内カルシウムを調節する化合物
|
|
US20130053382A1
(en)
|
2010-04-30 |
2013-02-28 |
Sunil Paliwal |
Inhibitors of Phosphoinositide Dependent Kinase 1 (PDK1)
|
|
WO2012025638A1
(en)
|
2010-08-27 |
2012-03-01 |
Universität des Saarlandes |
Selective 17beta-hydroxysteroid dehydrogenase type 1 inhibitors
|
|
CN104478882A
(zh)
|
2010-09-14 |
2015-04-01 |
波兰科学院生物化学与生物物理研究所 |
作为突变cftr蛋白的调节剂的化合物及其在治疗与cftr蛋白失常相关的疾病中的用途
|
|
KR101566091B1
(ko)
*
|
2010-11-10 |
2015-11-04 |
에프. 호프만-라 로슈 아게 |
Lrrk2 조절제로서 피라졸 아미노피리미딘 유도체
|
|
WO2012135631A1
(en)
|
2011-03-30 |
2012-10-04 |
Arrien Pharmaeuticals Llc |
Substituted 5-(pyrazin-2-yl)-1h-pyrazolo [3, 4-b] pyridine and pyrazolo [3, 4-b] pyridine derivatives as protein kinase inhibitors
|
|
EP2694060A4
(en)
|
2011-04-01 |
2014-09-10 |
Univ Utah Res Found |
SUBSTITUTED 3- (1H-BENZO- {D} -IMIDAZOL-2-YL-) 1H-INDAZOL ANALOGUE AS PDK1 KINASE INHIBITOR
|
|
WO2012162254A1
(en)
|
2011-05-23 |
2012-11-29 |
Elan Pharmaceuticals, Inc. |
Inhibitors of lrrk2 kinase activity
|
|
EP2773645A1
(en)
|
2011-11-01 |
2014-09-10 |
F.Hoffmann-La Roche Ag |
Imidazopyridazine compounds
|
|
US9012450B2
(en)
|
2011-12-28 |
2015-04-21 |
Global Blood Therapeutics, Inc. |
Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
|
|
EP2802324A4
(en)
|
2012-01-09 |
2015-07-15 |
X Rx Inc |
BENZHYDROL-PYRAZOLE DERIVATIVES WITH KINASE-INHIBITORY EFFECT AND USES THEREOF
|
|
WO2013151938A1
(en)
|
2012-04-02 |
2013-10-10 |
Cytokinetics, Inc. |
Methods for improving diaphragm function
|
|
US8962322B2
(en)
|
2012-12-03 |
2015-02-24 |
City Of Hope |
Enhancers of induced pluripotent stem cell reprogramming
|
|
TWI662030B
(zh)
|
2013-01-15 |
2019-06-11 |
英塞特控股公司 |
適用作ｐｉｍ激酶抑制劑之噻唑甲醯胺及吡啶甲醯胺化合物
|
|
WO2014134774A1
(en)
|
2013-03-04 |
2014-09-12 |
Merck Sharp & Dohme Corp. |
Compounds inhibiting leucine-rich repeat kinase enzyme activity
|
|
US20160024071A1
(en)
|
2013-03-15 |
2016-01-28 |
Elan Pharmaceuticals, Llc |
Inhibitors of lrrk2 kinase activity
|
|
US10005720B2
(en)
|
2013-04-05 |
2018-06-26 |
North Carolina Central University |
Compounds useful for the treatment of metabolic disorders and synthesis of the same
|
|
RU2015149937A
(ru)
|
2013-05-30 |
2017-07-06 |
Плексксикон Инк. |
Соединения для модулирования киназы и показания к их применению
|
|
KR20160015221A
(ko)
|
2013-06-06 |
2016-02-12 |
키에시 파르마슈티시 엣스. 피. 에이. |
키나아제 억제제
|
|
HK1220976A1
(zh)
|
2013-06-21 |
2017-05-19 |
F. Hoffmann-La Roche Ag |
作为rorc调节剂的芳基磺内酰胺衍生物
|
|
CU24398B1
(es)
|
2013-08-02 |
2019-04-04 |
Pfizer |
3-(piperidin,pirrol o azetidin)-indoles sustituidos útiles como inhibidores rorc2
|
|
WO2015026683A1
(en)
|
2013-08-22 |
2015-02-26 |
Merck Sharp & Dohme Corp. |
Compounds inhibiting leucine-rich repeat kinase enzyme activity
|
|
AU2014369053B2
(en)
|
2013-12-20 |
2019-03-14 |
Institute For Drug Discovery, Llc |
Substituted amino triazoles, and methods using same
|
|
US10954240B2
(en)
|
2014-09-03 |
2021-03-23 |
Merck Sharp & Dohme Corp. |
Compounds inhibiting leucine-rich repeat kinase enzyme activity
|
|
US20160113931A1
(en)
|
2014-10-24 |
2016-04-28 |
University Of Macau |
Method of treating and/or preventing neurodegenerative diseases
|
|
HK1243636A1
(zh)
|
2014-11-18 |
2018-07-20 |
Rutgers, The State University Of New Jersey |
用於治疗代谢疾病和癌症的新的线粒体解偶联剂
|
|
JO3705B1
(ar)
|
2014-11-26 |
2021-01-31 |
Bayer Pharma AG |
إندازولات مستبدلة جديدة، عمليات لتحضيرها، مستحضرات دوائية تحتوي عليها واستخدامها في إنتاج أدوية
|
|
EP3270694A4
(en)
|
2015-02-17 |
2018-09-05 |
Neupharma, Inc. |
Certain chemical entities, compositions, and methods
|
|
US10766860B2
(en)
|
2015-03-06 |
2020-09-08 |
Pharmakea, Inc. |
Lysyl oxidase-like 2 inhibitors and uses thereof
|
|
US10975081B2
(en)
*
|
2015-07-23 |
2021-04-13 |
Glaxosmithkline Intellectual Property Development Limited |
Substituted fused pyrazole compounds and their use as LRRK2 inhibitors
|
|
CA2995094A1
(en)
|
2015-08-07 |
2017-02-16 |
Calcimedica, Inc. |
Use of crac channel inhibitors for the treatment of stroke and traumatic brain injury
|
|
US10626081B2
(en)
|
2015-09-16 |
2020-04-21 |
Metacrine, Inc. |
Farnesoid X receptor agonists and uses thereof
|
|
WO2017049409A1
(en)
|
2015-09-25 |
2017-03-30 |
The Centre For Drug Research And Development |
Compositions for promoting readthrough of premature termination codons, and methods of using the same
|
|
TW201808906A
(zh)
|
2016-03-16 |
2018-03-16 |
拜耳作物科學股份有限公司 |
作為殺蟲劑之經取代吡啶化合物
|
|
MA43753A
(fr)
|
2016-03-24 |
2018-11-28 |
Mission Therapeutics Ltd |
Dérivés 1-cyano-pyrrolidine comme inhibiteurs de dbu
|
|
US10933068B2
(en)
*
|
2016-05-26 |
2021-03-02 |
Sonic Master Limited |
Modulators of DUX4 for regulation of muscle function
|
|
TWI800498B
(zh)
|
2016-12-21 |
2023-05-01 |
義大利商吉斯藥品公司 |
作為Rho-激酶抑制劑之雙環二氫嘧啶-羧醯胺衍生物
|
|
CN110248936A
(zh)
|
2017-01-25 |
2019-09-17 |
葛兰素史密斯克莱知识产权发展有限公司 |
化合物
|
|
BR112019015273A2
(pt)
|
2017-01-25 |
2020-04-14 |
Glaxosmithkline Ip Dev Ltd |
compostos
|
|
WO2018137607A1
(en)
|
2017-01-25 |
2018-08-02 |
Glaxosmithkline Intellectual Property Development Limited |
Compounds
|
|
EP3573971A1
(en)
|
2017-01-26 |
2019-12-04 |
Araxes Pharma LLC |
1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1yl)prop-2-en-1-one derivatives and similar compounds as kras g12c modulators for treating cancer
|
|
EP3621962A4
(en)
|
2017-05-10 |
2020-12-09 |
Forge Therapeutics, Inc. |
ANTIBACTERIAL COMPOUNDS
|
|
CN107176932B
(zh)
|
2017-05-26 |
2020-06-05 |
中国药科大学 |
苯并恶嗪酮衍生物及其制备方法和用途
|
|
WO2019002624A1
(de)
|
2017-06-30 |
2019-01-03 |
Kleuser, Burkhard |
Mittel zur therapie entzündlicher darmerkrankungen
|
|
KR102687118B1
(ko)
|
2017-08-16 |
2024-07-19 |
벤더르빌트 유니버시티 |
Mglur4 알로스테릭 증강제로서의 인다졸 화합물, 조성물, 및 신경 기능장애 치료 방법
|
|
EP3694330B1
(en)
|
2017-10-11 |
2023-04-19 |
Merck Sharp & Dohme LLC |
Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as lrrk2 inhibitors, pharmaceutical compositions, and uses thereof
|
|
US11174248B2
(en)
|
2017-10-11 |
2021-11-16 |
Merck Sharp & Dohme Corp. |
Indazolyl-spiro[2.3]hexane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
|
|
AU2018361971A1
(en)
|
2017-11-03 |
2020-06-04 |
Universite De Montreal |
Compounds and use thereof in the expansion of stem cells and/or progenitor cells
|
|
US20210261553A1
(en)
|
2018-05-15 |
2021-08-26 |
E-Scape Bio, Inc. |
Fused tetrazoles as lrrk2 inhibitors
|
|
EP3873471B1
(en)
|
2018-10-31 |
2025-12-31 |
Merck Sharp & Dohme LLC |
N-HETEROARYL INDAZOLE DERIVATIVES AS LRRK2 INHIBITORS: PHARMACEUTICAL COMPOSITIONS AND THEIR USES
|
|
WO2020135513A1
(zh)
|
2018-12-25 |
2020-07-02 |
上海美悦生物科技发展有限公司 |
一种作为irak抑制剂的化合物
|
|
US20220162192A1
(en)
|
2019-03-21 |
2022-05-26 |
ESCAPE Bio, Inc. |
Indazoles as lrrk2 inhibitors
|
|
US20210386721A1
(en)
|
2019-05-10 |
2021-12-16 |
Shanghai Haiyan Pharmaceutical Technology Co., Ltd. |
Substituted phenylpropenyl pyridine derivatives, their preparation and pharmaceutical applications
|
|
WO2020247298A2
(en)
|
2019-06-06 |
2020-12-10 |
Merck Sharp & Dohme Corp. |
1-pyrazolyl, 5-, 6- disubstituted indazole derivatives as lrrk2 inhibitors, pharmaceutical compositions, and uses thereof
|
|
WO2021050688A1
(en)
|
2019-09-10 |
2021-03-18 |
X-Chem, Inc. |
Compounds and uses thereof
|
|
CN114072387B
(zh)
|
2019-11-06 |
2024-03-08 |
暨南大学 |
吲唑类化合物及其药用组合物和应用
|
|
CA3181786A1
(en)
|
2020-05-01 |
2021-11-04 |
The Regents Of The University Of California |
Inhibitors of alpha 2 beta 1 integrin and methods of use thereof
|